orchid pharma antibiotic 'exblifeb' gets approval from european medicines agency | cnbc tv18
Published 6 months ago • 1.2K plays • Length 2:01
Download video MP4
Download video MP3
Similar videos
-
5:00
orchid pharma partners with cipla for antibiotic cefepime-enmetazobactam, launch likely in august
-
5:35
according to estimates, sales of exblifeb could hit $2-3bn in the next 10 yrs: orchid pharma
-
7:17
cdmo business has been seeing margin of 14-15%: akums drugs & pharma | cnbc tv18
-
1:09
orchid pharma under pressure. revenue & margin decline on qoq basis | cnbc tv18
-
2:40
orchid pharma gets us fda nod for novel drug enmetazobactum used to treat urinary tract infection
-
2:40
okra water: is bhindi ka paani the next superfood? | ish news
-
16:19
travel to largest orchid farm in kanyakumari | orchid plant care and business ideas | tamil vlog
-
3:56
hogan lovells partner explains why predictability is so important for dealmakers
-
8:36
dcgi has asked for phase 4 clinical trials for enmetazobactam drug: orchid pharma | cnbc tv18
-
2:00
zydus under pressure after teva gets us fda approval for asacol hd generic | cnbc tv18
-
1:04
orchid pharma launches`400 cr qip, indicative issue price at ₹403.93/sh as per sources | cnbc tv18
-
2:40
spotlight on pharma stocks: what is aiding the outperformance? | cnbc tv18
-
1:17
orchid pharma surges in trade after investec initiates a 'buy' rating with target of ₹800 |cnbc tv18
-
2:33
zydus life dips over 5% after teva gets us fda approval for asacol hd generic | cnbc tv18
-
1:11
emcure pharma gains after jefferies initiates coverage with buy rating & target price of ₹1,600
-
2:41
pharma sector: nifty pharma in good health, valuation pictures & more | here's the details | et now
-
30:00
orchid pharma q4 fy24 earnings call part1- orchid pharma ltd q4 concall
-
6:44
co growing at 15-20% per annum & hope to continue growth momentum for next 3-4 yrs: orchid pharma
-
3:05
health-care industry's 'center of gravity' is shifting rapidly from west to east: quadria capital
-
6:41
key stocks in focus: medi assist, gpt infraprojects, ceigall, zydus lifesciences, hcltech, coforge
-
1:43
usfda inspection of eugia-iii unit of aurobindo pharma underway, stock under pressure | cnbc tv18
-
3:38
autos, health care and pharma among sectors to watch for ipos: freshfields
Clip.africa.com - Privacy-policy